Treatment of refractory Eosinophilia-Myalgia Syndrome with L-try

Details Treatment of refractory Eosinophilia-Myalgia Syndrome with L-try Treatment of refractory Eosinophilia-Myalgia Syndrome with L-try

1990-05-02

1993-02-09

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

424439, 424441, 424463, 424464, 424451, 514419, 514923, 530403, 530832, A61K 4742, A61K 920, A61K 3140, C07K 304

Patent

active

051851571

ABSTRACT:
A method of treating a human patient with refractory Eosinophilia Myalgia Syndrome via oral administration of an effective dosage range of from 1000 mg. to 3000 mg. of a pharmaceutical composition, in unit dosage form, comprising a minor amount of a solid or liquid carrier and a major amount of the amino acid, pharmaceutical grade L-tryptophan, or its acid addition salt, with both of the carriers and the amino acid to be selected to exclude the zinc, magnesium, and calcium containing salts as adjuvants.

REFERENCES:
patent: 4897380 (1990-01-01), Pollack
"The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion-Clinical Features in 20 Patients and Aspects of Pathophysiology".

Affiliated with

Also associated with

Rating

Treatment of refractory Eosinophilia-Myalgia Syndrome with L-try does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of refractory Eosinophilia-Myalgia Syndrome with L-try, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of refractory Eosinophilia-Myalgia Syndrome with L-try will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-324435